Disclosure of Transactions. On or before 5:30 p.m., New York time, on the 4th Business Day following the date of this Agreement, the Company shall file a Current Report on Form 8-K (or other form permitted under the federal securities law) disclosing the material terms and conditions of the transactions contemplated by this Agreement, the Warrant and the Concurrent Financing, in compliance with the requirements of Form 8-K (or such other form).
Appears in 6 contracts
Samples: Securities Purchase and Registration Rights Agreement (Star Scientific Inc), Securities Purchase and Registration Rights Agreement (Star Scientific Inc), Securities Purchase and Registration Rights Agreement (Star Scientific Inc)
Disclosure of Transactions. On The Company shall, on or before 5:30 p.m., 9:00 a.m. New York time, on the 4th fourth (4th) Business Day following the date of this Agreement, the Company shall file a Current Report on Form 8-K (or other form permitted under the federal securities law) disclosing 8‑K describing all the material terms and conditions of the transactions contemplated by this AgreementAgreement in the form required by the Securities Exchange Act of 1934, as amended, and attaching all the Warrant and the Concurrent Financing, in compliance with the requirements of Form 8-K (or such other form)material Transaction Documents.
Appears in 3 contracts
Samples: Exchange Agreement (Viggle Inc.), Exchange Agreement (Viggle Inc.), Exchange Agreement (Viggle Inc.)
Disclosure of Transactions. On or before 5:30 p.m., New York time, on the 4th Business Day fourth (4th) business day following the date of this Agreement, the Company shall file a Current Report on Form 8-K (or other form permitted under the federal securities law) disclosing the material terms and conditions of the transactions contemplated by this Agreement, the Warrant Agreement and the Concurrent FinancingWarrant, in compliance with the requirements of Form 8-K (or such other form)., unless such disclosure is first provided in the Company’s Quarterly Report on Form 10-Q.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Rock Creek Pharmaceuticals, Inc.), Securities Purchase Agreement (Rock Creek Pharmaceuticals, Inc.)
Disclosure of Transactions. On The Company shall, on or before 5:30 p.m., 9:00 a.m. New York time, on the 4th fourth (4th) Business Day following the date of this Agreement, the Company shall file a Current Report on Form 8-K (or other form permitted under the federal securities law) disclosing describing all the material terms and conditions of the transactions contemplated by the Transaction Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including, without limitation, this Agreement, the Warrant form of the New Note, the form of Security Agreement and the Concurrent Financing, in compliance with the requirements form of Form 8-K (or such other formGuaranty).
Appears in 2 contracts
Samples: Exchange Agreement (Viggle Inc.), Exchange Agreement (Viggle Inc.)
Disclosure of Transactions. On The Company shall, on or before 5:30 p.m., 9:00 a.m. New York time, on the 4th fourth (4th) Business Day following the date of this Agreement, the Company shall file a Current Report on Form 8-K 8‑K (or other form permitted under the federal securities lawdisclose in its Annual report on Form 10-K) disclosing describing all the material terms and conditions of the transactions contemplated by this Agreement, the Warrant Transaction Documents in the form required by the 1934 Act and attaching all the Concurrent Financing, in compliance with the requirements of Form 8-K (or such other form)material Transaction Documents.
Appears in 1 contract
Disclosure of Transactions. On The Company shall, on or before 5:30 p.m., 9:00 a.m. New York time, on the 4th fourth (4th) Business Day following the date of this Agreement, the Company shall file a Current Report on Form 8-K (or other form permitted under the federal securities law) disclosing describing all the material terms and conditions of the transactions contemplated by this Agreement in the form required by the Securities Exchange Act of 1934, as amended, and attaching this Agreement, the Warrant and the Concurrent Financing, in compliance with the requirements of Form 8-K (or such other form).
Appears in 1 contract
Samples: Exchange Agreement (Viggle Inc.)
Disclosure of Transactions. On or before 5:30 p.m., New York time, on the 4th Business Day second (2nd) business day following the date of this Agreement, the Company shall file a Current Report on Form 8-K (or other form permitted under the federal securities law) disclosing the material terms and conditions of the transactions contemplated by this Agreement, the Warrant Agreement and the Concurrent FinancingWarrants, in compliance with the requirements of Form 8-K (or such other form).
Appears in 1 contract
Samples: Securities Purchase and Registration Rights Agreement (Rock Creek Pharmaceuticals, Inc.)
Disclosure of Transactions. On or before 5:30 p.m., New York time, on the 4th Business Day fourth (4th) business day following the date of this Agreement, the Company shall file a Current Report on Form 8-K (or other form permitted under the federal securities law) disclosing the material terms and conditions of the transactions contemplated by this Agreement, the Warrant and the Concurrent Financing, in compliance with the requirements of Form 8-K (or such other form).
Appears in 1 contract
Samples: Securities Purchase and Registration Rights Agreement (Rock Creek Pharmaceuticals, Inc.)
Disclosure of Transactions. On or before 5:30 p.m., New York time, on the 4th Business Day first (1st) business day following the date of this Agreement, the Company shall file a Current Report on Form 8-K (or other form permitted under the federal securities law) disclosing the material terms and conditions of the transactions contemplated by this Agreement, the Warrant and the Concurrent Financing, Agreement in compliance with the requirements of Form 8-K (or such other form).
Appears in 1 contract
Samples: Securities Purchase and Registration Rights Agreement (BioCardia, Inc.)